4.7 Article

Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database

Journal

JMIR PUBLIC HEALTH AND SURVEILLANCE
Volume 7, Issue 11, Pages -

Publisher

JMIR PUBLICATIONS, INC
DOI: 10.2196/25976

Keywords

ovarian epithelial carcinoma; survivors; histology; survival rate; survival; ovarian; cancer; surveillance; epidemiology; women's health; reproductive health; Surveillance; Epidemiology; and End Results; ovary; oncology; survivorship; long-term outcome; epithelial

Funding

  1. National Natural Science Foundation of China [81802600]
  2. Science and Technology Planning Projects of Xiamen Science & Technology Bureau [3502Z20184016]
  3. Baise City Scientific Research and Technology Development Plan [20183008]

Ask authors/readers for more resources

This study analyzed data of advanced epithelial ovarian cancer patients to assess the role of histological subtypes in predicting prognosis among long-term survivors. Different histological subtypes showed varying probabilities of death, with serous subtype associated with higher mortality from primary ovarian cancer. Individualized surveillance programs are important for long-term ovarian cancer survivors.
Background: Actual long-term survival rates for advanced epithelial ovarian cancer (EOC) are rarely reported. Objective: This study aimed to assess the role of histological subtypes in predicting the prognosis among long-term survivors Methods: We performed a retrospective analysis of data among patients with stage III-IV EOC diagnosed from 2000 to 2014 using the Surveillance, Epidemiology, and End Results cancer data of the United States. We used the chi-square test, Kaplan-Meier analysis, and multivariate Cox proportional hazards model for the analyses. Results: We included 8050 patients in this study, including 6929 (86.1%), 743 (9.2%), 237 (2.9%), and 141 (1.8%) patients with serous, endometrioid, clear cell, and mucinous tumors, respectively. With a median follow-up of 91 months, the most common cause of death was primary ovarian cancer (80.3%), followed by other cancers (8.1%), other causes of death (7.3%), cardiac-related death (3.2%), and nonmalignant pulmonary disease (3.2%). Patients with the serous subtype were more likely to die from primary ovarian cancer, and patients with the mucinous subtype were more likely to die from other cancers and cardiac-related disease. Multivariate Cox analysis showed that patients with endometrioid (hazard ratio [HR] 0.534, P<.001), mucinous (HR 0.454, P<.001), and clear cell (HR 0.563, P<.001) subtypes showed better ovarian cancer-specific survival than those with the serous subtype. Similar results were found regarding overall survival. However, ovarian cancer-specific survival and overall survival were comparable among those with endometrioid, clear cell, and mucinous tumors. Conclusions: Ovarian cancer remains the primary cause of death in long-term ovarian cancer survivors. Moreover, the probability of death was significantly different among those with different histological subtypes. It is important for clinicians to individualize the surveillance program for long-term ovarian cancer survivors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available